CIK: 1665124 - Address: C/O Taysha Gene Therapies, Inc., 3000 Pegasus Park Drive, Suite 1430, Dallas, TX 75247
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret112-3-86000-1
S%wins100100067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/5/18 16:36
3/1/18
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-225126.190-2-1000D
2/5/18 16:58
2/1/18
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-210117.960-2-1000D
1/4/18 17:38
1/2/18
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-195109.720-2-1000D
12/5/17 18:32
12/1/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-16994.770-2-1000D
11/3/17 17:01
11/1/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-180101.260-2-1000D
10/3/17 17:05
10/2/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-17397.250-2-1000D
9/5/17 17:22
9/1/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-16693.250-2-1000D
8/3/17 17:02
8/1/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-16391.520-2-1000D
7/5/17 18:05
7/3/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-14681.880-2-1000D
6/2/17 16:33
6/1/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-12670.910-2-1000D
5/2/17 16:59
5/1/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-14581.3926-2-1000D230735632177-2-5
4/5/17 17:16
4/3/17
AVXSAvexis, Inc.DEHealthBioPrdBiological Products, (No DiagNagendran SukumarILOSVP,ChieS.d-13676.1333-2-1000D177806032110-3-106

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact